News Analysis

HHS, FDA Expand Access to Open Health Data

The Obama administration has released new datasets on adverse drug events and Medicare pricing. This offers researchers and developers alike a chance to build novel applications and identify cost trends, all in the name of improving efficiency and providing better healthcare while lowering costs.